Platform
Features
Pricing
0 followers
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression.
Industries
Headquarters
Employees
Links
Marie Labus
4 members
5 members
Oxford BioMedica
2 followers
Tango Therapeutics
Vaxcyte
Ensoma
1 follower
Aurion Biotech
Phylos
Cellares
SourceWhale
Volt
4 followers
Incident.io
Manual
3 followers
Explore companies